LivaNova (LIVN) Shares Outstanding (Diluted Average) (2014 - 2026)
LivaNova recorded quarterly Shares Outstanding (Diluted Average) of $55.9 million in Q1 2026, up 2.56% quarter-over-quarter from $54.5 million in Q4 2025, and up 2.8% year-over-year from $54.4 million in Q1 2025.
LivaNova's Shares Outstanding (Diluted Average) history runs 13 years deep, the most recent figure standing at $55.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) rose 2.8% year-over-year to $55.9 million; the TTM figure through Mar 2026 stood at $55.9 million (up 2.8% YoY), while the FY2025 annual figure was $54.5 million, changed 0.05% from the prior year.
- Shares Outstanding (Diluted Average) came in at $55.9 million for Q1 2026 at LivaNova, up from $54.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $55.9 million in Q1 2026 to a low of $53.5 million in Q4 2022.
- A 5-year average of $54.3 million and a median of $54.2 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
- Across the five-year window, Shares Outstanding (Diluted Average) climbed 11.16% in 2022 and declined 0.51% in 2023, its largest moves.
- LivaNova's Shares Outstanding (Diluted Average) stood at $53.5 million in 2022, then climbed by 1.38% to $54.2 million in 2023, then climbed by 0.67% to $54.6 million in 2024, then retreated by 0.05% to $54.5 million in 2025, then climbed by 2.56% to $55.9 million in 2026.
- According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $55.9 million, $54.5 million, and $54.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 55.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.94 Mn |
| Dec 31, 2025 | 54.55 Mn |
| Sep 30, 2025 | 54.53 Mn |
| Jun 30, 2025 | 54.71 Mn |
| Mar 31, 2025 | 54.42 Mn |
| Dec 31, 2024 | 54.57 Mn |
| Sep 30, 2024 | 54.53 Mn |
| Jun 30, 2024 | 54.59 Mn |
| Mar 31, 2024 | 54.01 Mn |
| Dec 31, 2023 | 54.21 Mn |
| Sep 30, 2023 | 53.99 Mn |
| Jun 30, 2023 | 53.94 Mn |
| Mar 31, 2023 | 53.90 Mn |
| Dec 31, 2022 | 53.47 Mn |
| Sep 30, 2022 | 53.53 Mn |
| Jun 30, 2022 | 54.08 Mn |
| Mar 31, 2022 | 54.18 Mn |
| Dec 31, 2021 | 50.63 Mn |
| Sep 30, 2021 | 51.58 Mn |
| Jun 30, 2021 | 48.83 Mn |
| Mar 31, 2021 | 48.74 Mn |
| Dec 31, 2020 | 48.59 Mn |
| Sep 30, 2020 | 48.58 Mn |
| Jun 30, 2020 | 48.61 Mn |
| Mar 31, 2020 | 48.77 Mn |
| Dec 31, 2019 | 48.35 Mn |
| Sep 30, 2019 | 48.82 Mn |
| Jun 30, 2019 | 48.30 Mn |
| Mar 31, 2019 | 48.25 Mn |
| Dec 31, 2018 | 48.50 Mn |
| Sep 30, 2018 | 49.43 Mn |
| Jun 30, 2018 | 49.26 Mn |
| Mar 31, 2018 | 49.19 Mn |
| Dec 31, 2017 | 48.50 Mn |
| Sep 30, 2017 | 48.53 Mn |
| Jun 30, 2017 | 48.30 Mn |
| Mar 31, 2017 | 48.18 Mn |
| Dec 31, 2016 | 49.01 Mn |
| Sep 30, 2016 | 49.08 Mn |
| Jun 30, 2016 | 48.99 Mn |
| Mar 31, 2016 | 48.92 Mn |
| Dec 31, 2015 | 32.74 Mn |
| Oct 18, 2015 | 26.02 Mn |
| Jul 24, 2015 | 26.23 Mn |
| Apr 24, 2015 | 26.63 Mn |
| Dec 26, 2014 | 26.78 Mn |
| Oct 24, 2014 | 26.87 Mn |
| Apr 25, 2014 | 27.47 Mn |